Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 944 | 846 | 665 | 1,242 | 825 |
| Cost of Goods | 350 | 340 | 300 | 450 | 310 |
| Gross Profit | 600 | 500 | 360 | 780 | 530 |
| Operating Expenses | 980 | 860 | 770 | 950 | 1,070 |
| Operating Income | -36 | -14 | -105 | 292 | -245 |
| Other Income | 11 | 9 | 15 | -2 | 35 |
| Pre-tax Income | -25 | -5 | -90 | 290 | -210 |
| Income Tax | -50 | 0 | -30 | 110 | -80 |
| Net Income Continuous | 34 | -5 | -58 | 172 | -128 |
| Net Income | $34 | $-5 | $-58 | $172 | $-128 |
| EPS Basic Total Ops | 0.01 | 0.00 | -0.02 | 0.06 | -0.05 |
| EPS Basic Continuous Ops | 0.01 | 0.00 | -0.02 | 0.06 | -0.05 |
| EPS Diluted Total Ops | 0.01 | 0.00 | -0.02 | 0.06 | -0.05 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | -0.02 | 0.06 | -0.05 |
| EBITDA(a) | $54 | $46 | $-45 | $352 | $-185 |